Yoshimura Y, Nakayama A, Oguchi J, Matsuda J, Kamakura M, Kinoshita T, Kazama M, Yamanaka M, Kida I, Abe T
Rinsho Ketsueki. 1989 Mar;30(3):332-7.
Essential thrombocythemia is a myeloproliferative disorder not known to have consistent cytogenetic abnormalities. A 38-year-old woman with essential thrombocythemia having Philadelphia chromosome (Ph1) is reported. The patient first presented with gastrointestinal bleeding, accompanied by thrombocytosis. Treatment of the gastrointestinal bleeding did not influence the elevation of platelet counts. The patient's clinical and hematological manifestations were consistent with essential thrombocythemia, but not with any other myeloproliferative diseases. Ph1 chromosome was constantly proved in bone marrow preparations from this patient over two years and four months and gave us a certain impression that Ph1 chromosome might have had some relation to development of essential thrombocythemia to chronic myelogenous leukemia in this patient.
原发性血小板增多症是一种髓系增殖性疾病,目前尚不知其有一致的细胞遗传学异常。本文报告了一名患有费城染色体(Ph1)的38岁原发性血小板增多症女性患者。该患者最初表现为胃肠道出血,并伴有血小板增多症。胃肠道出血的治疗并未影响血小板计数的升高。患者的临床和血液学表现与原发性血小板增多症相符,但与任何其他髓系增殖性疾病不符。在两年零四个月的时间里,该患者的骨髓涂片不断检测出Ph1染色体,这使我们有一定的印象,即Ph1染色体可能与该患者原发性血小板增多症向慢性粒细胞白血病的发展存在某种关联。